CCO Stock Overview
Operates as a health and wellness company in Australia, Fiji, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
The Calmer Co International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.008 |
| 52 Week High | AU$0.02 |
| 52 Week Low | AU$0.003 |
| Beta | 1.51 |
| 11 Month Change | -20.00% |
| 3 Month Change | 0% |
| 1 Year Change | 33.36% |
| 33 Year Change | -91.40% |
| 5 Year Change | -91.58% |
| Change since IPO | -93.33% |
Recent News & Updates
Shareholder Returns
| CCO | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 0% | -7.6% | 0.9% |
| 1Y | 33.4% | 54.1% | 18.4% |
Return vs Industry: CCO underperformed the Australian Personal Products industry which returned 54.5% over the past year.
Return vs Market: CCO exceeded the Australian Market which returned 17.7% over the past year.
Price Volatility
| CCO volatility | |
|---|---|
| CCO Average Weekly Movement | 15.0% |
| Personal Products Industry Average Movement | 5.6% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: CCO's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: CCO's weekly volatility has decreased from 29% to 15% over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Anthony Noble | www.thecalmerco.com |
The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; cold pressed shots and kava under the Taki Mai brand name; hemp, CBD oils, topical products, and kava tinctures under Danodan brand name; and nutraceuticals. It also markets Leilo kava beverages.
The Calmer Co International Limited Fundamentals Summary
| CCO fundamental statistics | |
|---|---|
| Market cap | AU$17.61m |
| Earnings (TTM) | -AU$3.73m |
| Revenue (TTM) | AU$4.26m |
4.1x
P/S Ratio-4.7x
P/E RatioIs CCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CCO income statement (TTM) | |
|---|---|
| Revenue | AU$4.26m |
| Cost of Revenue | AU$2.21m |
| Gross Profit | AU$2.05m |
| Other Expenses | AU$5.78m |
| Earnings | -AU$3.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0017 |
| Gross Margin | 48.08% |
| Net Profit Margin | -87.42% |
| Debt/Equity Ratio | -425.4% |
How did CCO perform over the long term?
See historical performance and comparison